Thompson A - Search Results

1

Value of Data Sharing to Advance Drug Development: A Regulatory Perspective.

Thompson A, Parekh A. Thompson A, et al. Ther Innov Regul Sci. 2021 Jul;55(4):850-852. doi: 10.1007/s43441-021-00275-y. Epub 2021 Apr 19. Ther Innov Regul Sci. 2021. PMID: 33876396

2

Biomarkers of drug-induced acute kidney injury: a regulatory perspective.

Blank M, Thompson A, Hausner E, Rouse R. Blank M, et al. Among authors: thompson a. Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):929-936. doi: 10.1080/17425255.2018.1511701. Epub 2018 Aug 16. Expert Opin Drug Metab Toxicol. 2018. PMID: 30099912 Review.

3

African Americans, Kidney Disease, and Drug Development: A Regulatory Perspective.

Panico C, Thompson A. Panico C, et al. Among authors: thompson a. Am J Kidney Dis. 2018 Nov;72(5 Suppl 1):S33-S36. doi: 10.1053/j.ajkd.2018.06.023. Am J Kidney Dis. 2018. PMID: 30343721 Review.

4

Qualification of cardiac troponins for nonclinical use: a regulatory perspective.

Hausner EA, Hicks KA, Leighton JK, Szarfman A, Thompson AM, Harlow P. Hausner EA, et al. Among authors: thompson am. Regul Toxicol Pharmacol. 2013 Oct;67(1):108-14. doi: 10.1016/j.yrtph.2013.07.006. Epub 2013 Jul 20. Regul Toxicol Pharmacol. 2013. PMID: 23876748 Review.

5

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.

Mol PGM, Thompson A, Heerspink HJL, Leufkens HGM. Mol PGM, et al. Among authors: thompson a. Diabetes Obes Metab. 2018 Oct;20 Suppl 3(Suppl Suppl 3):19-23. doi: 10.1111/dom.13453. Diabetes Obes Metab. 2018. PMID: 30294953 Free PMC article. Review.

6

Evaluating the Renal Safety of Investigational New Drugs: Where Should We Be Going?

Stockbridge N, Blank M, Hausner EA, Thompson A. Stockbridge N, et al. Among authors: thompson a. Clin Pharmacol Ther. 2017 Sep;102(3):387-388. doi: 10.1002/cpt.745. Epub 2017 Jul 21. Clin Pharmacol Ther. 2017. PMID: 28731221

7

FDA Regulatory Perspectives for Studies on Hemodialysis Vascular Access.

Hurst FP, Lee RE, Thompson AM, Pullin BD, Silverstein DM. Hurst FP, et al. Clin J Am Soc Nephrol. 2018 Mar 7;13(3):513-518. doi: 10.2215/CJN.02900317. Epub 2017 Jul 24. Clin J Am Soc Nephrol. 2018. PMID: 28739575 Free PMC article. Review.

8

Evaluating the Use of KIM-1 in Drug Development and Research Following FDA Qualification.

Chen R, Sanyal S, Thompson A, Ix JH, Haskins K, Muldowney L, Amur S. Chen R, et al. Among authors: thompson a. Clin Pharmacol Ther. 2018 Dec;104(6):1175-1181. doi: 10.1002/cpt.1093. Epub 2018 May 15. Clin Pharmacol Ther. 2018. PMID: 29761868 Free PMC article.

9

Real World Data and Evidence: Support for Drug Approval: Applications to Kidney Diseases.

Thompson AM, Southworth MR. Thompson AM, et al. Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1531-1532. doi: 10.2215/CJN.02790319. Epub 2019 Sep 6. Clin J Am Soc Nephrol. 2019. PMID: 31492691 Free PMC article. No abstract available.

10

Overcoming Barriers to Drug Development in Children with CKD.

Khurana M, Egger GF, Yao L, Thompson A, Pallidis C, Goldstein SL, Laskin BL, Tuchman S, Malley MA, Uhlig K. Khurana M, et al. Among authors: thompson a. Clin J Am Soc Nephrol. 2023 Aug 1;18(8):1101-1107. doi: 10.2215/CJN.0000000000000167. Epub 2023 Apr 13. Clin J Am Soc Nephrol. 2023. PMID: 37055225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,060 results

Search Page

Filters